Neurodegenerative Disease Technologies

Antibody based reagents that specifically recognize toxic oligomeric forms of beta-amyloid

Bi-specific Antibodies as a Therapeutic for Alzheimer’s Disease

Selective Clearance of Beta-Amyloid Using Bispecific Recombinant Antibody fragments

Recombinant Antibody Fragments that Selectively Target Oligomeric Tau Aggregates

High-resolution Flexible Neural Implant

Compounds to Modulate Retinoid X Receptors

Reagents Targeting Neurodegenerative Diseases and Traumatic Brain Injury

Compounds to Modulate Retinoid X Receptors

Compounds to Modulate Retinoid X Receptors

Compounds to Modulate Retinoid X Receptors